![](https://srfcure.org/wp-content/uploads/2024/06/CONQUEST-Header.jpg)
![](https://srfcure.org/wp-content/uploads/2024/06/CONQUEST-Header.jpg)
We are honored to announce that CONQUER has enrolled its 1,000th participant! 🎉 In 2018, the SRF launched the CONQUER Registry (an acronym for COllaborative National QUality and Efficacy Registry)—a first-of-its-kind nationwide…
SAN FRANCISCO, December 19, 2023 — The Scleroderma Research Foundation (SRF), the nation’s largest non-profit funder of scleroderma research, today announced that the FDA has cleared its Investigational New Drug…
Join us in welcoming the University of California, Los Angeles to the CONQUER Registry! UCLA recently joined the CONQUER Registry—a highly collaborative consortium of some of the largest scleroderma centers…
Your voice matters! The National Organization for Rare Disorders and the Rare Disease Diversity Coalition created a national survey for Rare Disease patients and caregivers. The survey focuses on people of color…